Lobbying

Ekaterra Tea Mso USA, LLC Dba Lipton Teas & Infusions's latest lobbying report covers Q3 2025, at under $5,000. Its first report covers Q1 2024; the issues it reports most are Food Industry (Safety, Labeling, etc.).

Ekaterra Tea Mso USA, LLC Dba Lipton Teas & Infusions

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2024
The first quarter a report named it

Lobbying by quarter

Ekaterra Tea Mso USA, LLC Dba Lipton Teas & Infusions lobbying by quarter
Ekaterra Tea Mso USA, LLC Dba Lipton Teas & Infusions lobbying by quarter
QuarterAmountReports
Q1 2024$30K1
Q2 2024$80K1
Q3 2024$80K1
Q4 2024$50K1
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Food industry$240K · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)4 reports
  • HOUSE OF REPRESENTATIVES4 reports
  • SENATE4 reports
  • Office of the Vice President of the United States2 reports

Firms it paid

Firm
Holland & Knight$240K7 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
25/10/18for Q3 2025Holland & KnightUnder $5,000
25/07/04for Q2 2025Holland & KnightUnder $5,000
25/04/13for Q1 2025Holland & KnightUnder $5,000
25/01/11for Q4 2024Holland & Knight$50K
24/10/09for Q3 2024Holland & Knight$80K
24/07/19for Q2 2024Holland & Knight$80K
24/04/22for Q1 2024Holland & Knight$30K
24/03/27for Q1 2024Holland & KnightUnder $5,000